160 related articles for article (PubMed ID: 9207366)
21. Pathogenesis of Clostridium perfringens infection: mechanisms and mediators of shock.
Stevens DL; Bryant AE
Clin Infect Dis; 1997 Sep; 25 Suppl 2():S160-4. PubMed ID: 9310664
[No Abstract] [Full Text] [Related]
22. [Protective properties of theta-hemolysin obtained by affinity chromatography].
Efimova MG; Blagoveshchenskiĭ VA; Khatuntseva BV
Zh Mikrobiol Epidemiol Immunobiol; 1982 Dec; (12):87-92. PubMed ID: 6297191
[TBL] [Abstract][Full Text] [Related]
23. Immunization with a nontoxic naturally occurring Clostridium perfringens alpha toxin induces neutralizing antibodies in rabbits.
Siqueira FF; Silva ROS; do Carmo AO; de Oliveira-Mendes BBR; Horta CCR; Lobato FCF; Kalapothakis E
Anaerobe; 2018 Feb; 49():48-52. PubMed ID: 29246841
[TBL] [Abstract][Full Text] [Related]
24. [Effect of immunomodulators on resistance to gas gangrene. The enhanced resistance of white mice to perfringens toxin type A as affected by prodigiozan].
Konikova RE; Stepanov AV; Sviridov LP
Zh Mikrobiol Epidemiol Immunobiol; 1986 Feb; (2):81-4. PubMed ID: 2870596
[TBL] [Abstract][Full Text] [Related]
25.
Takehara M; Seike S; Sonobe Y; Bandou H; Yokoyama S; Takagishi T; Miyamoto K; Kobayashi K; Nagahama M
Commun Biol; 2019; 2():45. PubMed ID: 30729183
[TBL] [Abstract][Full Text] [Related]
26. Reactive oxygen species and the MEK/ERK pathway are involved in the toxicity of clostridium perfringens α-toxin, a prototype bacterial phospholipase C.
Monturiol-Gross L; Flores-Díaz M; Araya-Castillo C; Pineda-Padilla MJ; Clark GC; Titball RW; Alape-Girón A
J Infect Dis; 2012 Oct; 206(8):1218-26. PubMed ID: 22904339
[TBL] [Abstract][Full Text] [Related]
27. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene.
Williamson ED; Titball RW
Vaccine; 1993 Sep; 11(12):1253-8. PubMed ID: 8256506
[TBL] [Abstract][Full Text] [Related]
28. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.
Nagahama M; Oda M; Kobayashi K; Ochi S; Takagishi T; Shibutani M; Sakurai J
Microbiol Immunol; 2013 May; 57(5):340-5. PubMed ID: 23668605
[TBL] [Abstract][Full Text] [Related]
29. Clostridium perfringens toxins (type A, B, C, D, E).
McDonel JL
Pharmacol Ther; 1980; 10(3):617-55. PubMed ID: 6255496
[No Abstract] [Full Text] [Related]
30. Ethanolamine utilization supports Clostridium perfringens growth in infected tissues.
Yagi H; Nakayama-Imaohji H; Nariya H; Tada A; Yamasaki H; Ugai H; Elahi M; Ono T; Kuwahara T
Microb Pathog; 2018 Jun; 119():200-207. PubMed ID: 29654901
[TBL] [Abstract][Full Text] [Related]
31. Clostridium perfringens α-Toxin Impairs Innate Immunity via Inhibition of Neutrophil Differentiation.
Takehara M; Takagishi T; Seike S; Ohtani K; Kobayashi K; Miyamoto K; Shimizu T; Nagahama M
Sci Rep; 2016 Jun; 6():28192. PubMed ID: 27306065
[TBL] [Abstract][Full Text] [Related]
32. Role of alpha-toxin in Clostridium perfringens infection determined by using recombinants of C. perfringens and Bacillus subtilis.
Ninomiya M; Matsushita O; Minami J; Sakamoto H; Nakano M; Okabe A
Infect Immun; 1994 Nov; 62(11):5032-9. PubMed ID: 7927785
[TBL] [Abstract][Full Text] [Related]
33. Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens.
Bryant AE; Chen RY; Nagata Y; Wang Y; Lee CH; Finegold S; Guth PH; Stevens DL
J Infect Dis; 2000 Sep; 182(3):799-807. PubMed ID: 10950774
[TBL] [Abstract][Full Text] [Related]
34. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
[TBL] [Abstract][Full Text] [Related]
35. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model.
Shreya D; Uppalapati SR; Kingston JJ; Sripathy MH; Batra HV
Mol Immunol; 2015 May; 65(1):51-7. PubMed ID: 25645504
[TBL] [Abstract][Full Text] [Related]
36. Enhanced production of phospholipase C and perfringolysin O (alpha and theta toxins) in a gatifloxacin-resistant strain of Clostridium perfringens.
Rafii F; Park M; Bryant AE; Johnson SJ; Wagner RD
Antimicrob Agents Chemother; 2008 Mar; 52(3):895-900. PubMed ID: 18160514
[TBL] [Abstract][Full Text] [Related]
37. Histotoxic Clostridial Infections.
Nagahama M; Takehara M; Rood JI
Microbiol Spectr; 2019 Jul; 7(4):. PubMed ID: 31350831
[TBL] [Abstract][Full Text] [Related]
38. Membrane-Binding Mechanism of Clostridium perfringens Alpha-Toxin.
Oda M; Terao Y; Sakurai J; Nagahama M
Toxins (Basel); 2015 Dec; 7(12):5268-75. PubMed ID: 26633512
[TBL] [Abstract][Full Text] [Related]
39. Clostridium perfringens α-toxin up-regulates plasma membrane CD11b expression on murine neutrophils by changing intracellular localization.
Takehara M; Kobayashi K; Nagahama M
Biochim Biophys Acta Biomembr; 2022 Dec; 1864(12):184054. PubMed ID: 36155052
[TBL] [Abstract][Full Text] [Related]
40. [Gas gangrene--case diagnosis].
Wojdat E; Kwiatek K; Zdrojewski H; Krupa L
Przegl Epidemiol; 2005; 59(4):859-63. PubMed ID: 16729427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
